Impact of motivational interviewing on psychosocial and symptom outcomes during breast cancer endocrine therapy
Open Access
- 23 August 2025
- journal article
- research article
- Published by Springer Nature in Supportive Care in Cancer
- Vol. 33 (9) , 1-8
Abstract
Purpose: Adjuvant endocrine therapy (ET) is recommended to women with hormone receptor-positive (HR +) breast cancer for 5–10 years to reduce recurrence risk and mortality, but adhering to ET for this full period is challenging due to the physical and psychosocial effects of treatment. We sought to understand how participation in a patient-centered counseling intervention affected anxiety and depression, recurrence worry, and treatment related symptoms. Methods: We conducted a single-arm pilot study over a 12-month period, consisting of five counselor-led motivational interviewing (MI) counseling sessions. Eligible participants were over 18 years old, English speaking, and had stage I-III HR + breast cancer. Survey data collected at baseline and 12 months assessed anxiety and depression, and cancer recurrence worry. Endocrine symptoms were assessed at the 12-month time point, reported descriptively, and age-stratified to examine if symptom burden and age were related. Results: Of the 42 women who initiated the intervention, 35 completed the baseline and 12-month surveys. Most participants were over 50 (63%), non-Black and non-Hispanic (63%; 97%). Overall patient-reported anxiety and depression decreased from baseline to 12 months, though only the change in anxiety was statistically significant, while cancer worry increased slightly. The most reported endocrine symptoms were hot flashes, night sweats, vaginal dryness, disinterest in sex, and joint pain; endocrine symptoms did not vary by age. Conclusion: This study shows early promise in the efficacy of MI to improve anxiety, depression, recurrence worry, and treatment-related endocrine symptoms.Keywords
All Related Versions
Funding Information
- National Cancer Institute (T32 CA116339)
- American Cancer Society (MRSG-13-157-01-CPPB)
This publication has 52 references indexed in Scilit:
- Comparison of Acupuncture vs Sham Acupuncture or Waiting List Control in the Treatment of Aromatase Inhibitor–Related Joint PainJAMA Network Open, 2022
- A telehealth intervention for symptom management, distress, and adherence to adjuvant endocrine therapy: A randomized controlled trialCancer, 2022
- Barriers to and facilitative processes of endocrine therapy adherence among women with breast cancerBreast Cancer Research and Treatment, 2016
- Self-efficacy for coping with symptoms moderates the relationship between physical symptoms and well-being in breast cancer survivors taking adjuvant endocrine therapySupportive Care in Cancer, 2014
- Clinical and biomarker predictors of side effects from tamoxifenBreast Cancer Research and Treatment, 2011
- Reducing vasomotor symptoms with acupuncture in breast cancer patients treated with adjuvant tamoxifen: a randomized controlled trialBreast Cancer Research and Treatment, 2010
- Weight gain is associated with increased risk of hot flashes in breast cancer survivors on aromatase inhibitorsBreast Cancer Research and Treatment, 2010
- Aromatase inhibitors for treatment of advanced breast cancer in postmenopausal womenCochrane Database of Systematic Reviews, 2009
- Adherence to tamoxifen over the five-year courseBreast Cancer Research and Treatment, 2006
- The Information‐Motivation‐Behavioral Skills Model: A General Social Psychological Approach to Understanding and Promoting Health Behavior2003